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Structured Abstract 
Objective: The etiology of cleft palate (CP) is poorly understood compared with that of cleft lip 
with or without palate (CL/P). Recently, variants in Grainyhead like transcription factor 3 
(GRHL3) were reported to be associated with a risk for CP in European and some African 
populations including Nigeria, Ghana, and Ethiopia. In order to identify genetic variants that may 
further explain the etiology of CP, we sequenced GRHL3 in a South African population to 
determine if rare variants in GRHL3 are associated with the presence of syndromic or 
nonsyndromic CP.  
Design: We prospectively sequenced the exons of GRHL3 in 100 cases and where possible, we 
also sequenced the parents of the individuals to determine the segregation pattern and presence 
of de novo variants. 
Setting: The cleft clinics from two public, tertiary hospitals in Durban, South Africa (SA), 
namely Inkosi Albert Luthuli Central Hospital (IALCH) and KwaZulu-Natal Children’s Hospital 
(KZNCH). 
Patients, participants: 100 patients with CL/P and their parents. 
Interventions: Saliva samples were collected. 
Main outcome measures: To ascertain the genetic variants in the GRHL3 gene in patients with 
CL/P in SA. 
Results: Five variants in GRHL3 were observed; three were novel (two intronic and one missense 
variant) and two are known variants. The novel variants were intronic variants, c.1062+77A>G 
and c.627+1G>A and missense variant, p.Asp169Gly. 
Conclusions: This study provides further evidence that variants in GRHL3 contribute to the risk 
of nonsyndromic CP in African populations, specifically, in the South African population. 
 










Orofacial clefts (OFC) are common craniofacial abnormalities occurring with a worldwide 
prevalence of 1 in 700 live births 1. However the prevalence of OFC differs according to 
ethnicity, race and geographical location. The highest reported prevalence of clefts occur in 
Asian populations, followed by Europeans, whereas African populations show the lowest 
prevalence 2. The rates range from as high as 1 in 500 births in Asians to as low as 1 in 2000 
births in Africans 3. 
Although South Africa does not have a current national birth defect registry, studies conducted 
using the Birth Defects Notification Tool form show that OFC represent one of the top five 
priority birth defects 4. The prevalence of OFCs in South Africa is estimated to be around 1 per 
3333 live births 5.  
There are biological and social effects with OFC and treatment aims should address the 
appearance, speech and hearing of an affected individual. This condition also places a significant 
psychological and economic burden on the individual, family and the healthcare service. 
However, good treatment outcomes are possible, especially in centres where a multidisciplinary 
OFC team approach is utilised.  
The clinical classification of OFC includes cleft lip with or without cleft palate (CL/P) and cleft 
palate (CP). The etiology of OFC is complex and multifactorial with influences from genetics, 
genomics, the environment and possible gene-environment interactions 6. 
The genetic etiology of CP alone is least understood and approximately 50% of all CP patients 
are nonsyndromic 6. To date, very little research has been done on the genetic etiology of OFCs 
in South Africa. The current study is part of a comprehensive project to identify the genetic and 
genomic causes of OFC in the South African population through the African Craniofacial 
Anomalies Network (AfriCRAN) 7. In this study, we screened the Grainyhead like transcription 
factor 3 (GRHL3) gene for variants in a cohort from South Africa. 
GRHL3 is a transcription factor that plays an important role in primary neurulation and in the 
differentiation of stratified epithelia of ectodermal or endodermal origin 8. GRHL3 has been 
previously associated with CP. Mutations were found in a Van Der Woude Syndrome (VWS) 
family with CP in a linkage and targeted sequencing study 9. Leslie et al. 2016 10 performed 
genome wide association studies (GWAS) of nonsyndromic CP and found an association with a 
missense variant in GRHL3. The result was replicated in an independent cohort. They concluded 
that the p.Thr454Met variant is an etiologic variant for nonsyndromic CP. In a parallel study, 
Mangold et al 2016 11 found a significant association between the p.Thr454Met variant in 
GRHL3 and nonsyndromic CP. 
Recently, variants of GRHL3 were found to be associated with risk for CP in African populations 
from Nigeria, Ghana and Ethiopia 12. The current study identified novel variants in GRHL3 that 
are associated with CP.  
 
Participants & Methods  
Study population 
Patients born with various OFC types and parents of these cases were recruited and assessed at 
the cleft clinics from two Durban hospitals in South Africa, namely Inkosi Albert Luthuli Central 
Hospital (IALCH) and KwaZulu-Natal Children’s Hospital (KZNCH). The assessment was 
conducted by the principal investigator, a paediatrician (TN); and findings were verified by 
plastic surgeons and an orthodontist. This was an observational clinical study to ascertain the 
genetic causes of cleft lip and palate in the African population in KwaZulu-Natal. Patients were 
consecutively selected from the cleft clinics. Eligible children must be  of African ancestry and 
have a CL/P. 
Informed consent was obtained from all participating families. A case report form was completed 
and saliva samples were collected with Oragene saliva kits and sponges (DNA Genotek). These 
samples were sent to the Butali Laboratory at the University of Iowa for processing and analysis. 
DNA from all samples was extracted, followed by XY genotyping analysis for quality control 
purposes to ensure that the sex of the sample matched the sex of the actual donor. A combination 
of 100 case-parent samples (dyads and triads) were collected and included for Sanger 
sequencing. Biomedical Research Ethics Committee clearance (BE309/18) was obtained from 
the University of KwaZulu-Natal. 
Sanger Sequencing 
Methods previously reported by our team were used to sequence DNA from humans 13. We 
optimized 13 primers for the amplification of 18 exons in the GRHL3 gene (NM_198174). We 
used 1ul of DNA in a 10-μL reaction for the polymerase chain reaction (PCR). Two Nigerian 
CEPH samples (NA18855 and NA18856) were added as template controls. The primers used and 
annealing temperatures are available from the Butali Laboratory upon request. The amplified 
DNA products were sequenced at Functional Biosciences (http://functionalbio.com) 
In order to identify novel and rare variants, every variant found in our isolated population were 
compared to those in the 1000 Genomes database, Exome Variant Server database 
(http://snp.gs.washington.edu/EVS/), and exomes in the Genome Aggregation Database 
(gnomAD; http://gnomad.broadinstitute.org). To predict the functional effects of these variants 
on the protein, we used bioinformatics tools, such as Combined Annotation Dependent Depletion 
(CADD; https://cadd.gs.washington.edu/; 14, Polymorphism Phenotyping (Polyphen; 
http://genetics.bwh.harvard.edu/pph2/; 15, Sorting Intolerant from Tolerant (SIFT; 
http://sift.jcvi.org/; 16, Have Your Protein Explained (HOPE; http://www.cmbi.ru.nl/hope; 17, and 
Human Splicing Finder (HSF; http://www.umd.be/HSF/) 18. To assess the inheritance patterns of 





We observed five variants in GRHL3, three were novel (two intronic and one missense variant) 
and two were known variants. The novel variants were missense variant, p.Asp169Gly and 
intronic variants, c.1062+77A>G and c.627+1G>A (Table 1). These novel variants were absent 
from all public exome and genome databases including over 8000 individuals from Africa.  
Segregation analyses for the novel missense variant, p.Asp169Gly, showed that the father had 
the variant even though he did not have CP implying that the phenotype was not completely 
penetrant. The patient’s paternal half-sister and first cousin, also had CP (Figures1 and 2).  
The missense mutation (p.Arg298Cys) was found in the 1000 Genomes database and was 
previously reported twice; in a Non-Finnish European population and a Southeast Asian 
population. However, this is the first report of the same mutation in an African population with 
phenotypic data.  
The known intronic variant (p.Arg16Gln) with the potential to alter splicing was identified in an 
individual with a cleft lip and alveolus. This variant was previously reported in East and West 
African populations. However, this is the first report in a South African population. 
According to HOPE (http://www.cmbi.ru.nl/hope), the novel missense mutation (p.Asp169Gly) 
affected the structure and function of the protein for a number of biochemical reasons. There was 
a difference in charge, size and hydrophobicity between the wild-type and variant amino acid. 
The charge of the wild-type residue was lost. This could cause loss of interactions with other 
molecules or residues. The mutant residue was smaller and this may lead to loss of interactions. 
Lastly, the mutation introduced a more hydrophobic residue in this position which could result in 
the loss of hydrogen bonds thereby disturbing correct folding of the GRHL3 protein (Figure 2). 
 
Discussion: 
In our variant screen study of GRHL3 families with OFC from South Africa, we identified  a 
novel missense variant (p.Asp169Gly) in a multiplex family with CP. The variant segregates in 
the family with the father carrying the variant. However, the father does not have a CP 
suggesting that there is incomplete penetrance.  
This novel missense variant (p.Asp169Gly) was not found in control databases that cumulatively 
has over 16,000 African alleles. PolyPhen-2 predicts the (p.Asp169Gly) variant is probably 
damaging while SIFT predicts that it is tolerated. The difference in effect prediction between the 
two in silico bioinformatics tools may be due to the design of the algorithms used for prediction 
of variant pathogenicity utilized by each tool. SIFT predicts whether an amino acid substitution 
is likely to affect protein function based on sequence homology and physico-chemical similarity 
between the alternate amino acids. The CADD score for this novel missense variant 
(p.Asp169Gly) is 26 suggesting that this variant is in the top 1% of deleterious variants in the 
genome. The PROVEAN score of -0.36 predicts that the variant has a neutral effect. The variant 
was absent from the 1000 Genomes, Exome Variant Server and gnomAD databases.  
 
The novel splice donor variant (c.627+1G>A) was found in intron 4 of a patient with CP. The 
variant has a high CADD score of 34, placing it in the top 0.1% of deleterious mutations in the 
genome. It caused alteration to the wild type donor site, which most probably affected splicing. 
The novel intronic variant (c.1062+77A>G) has a low CADD score of 0.104 and was found in a 
patient with bilateral cleft lip and palate with the right side having an incomplete cleft lip. This 
variant may not be associated with phenotype since variants in GRHL3 have only been 
previously associated with CP. 
The rare known missense variant (p.Arg298Cys) has been reported in the gnomAD database, 
however it is uncertain if these individuals had isolated CP. It has a CADD score of 26.7 and was 
predicted to be probably damaging and deleterious. The absence of phenotype in the control 
database makes it difficult to interpret this finding. Lastly, the known splicing variant 
(p.Arg16Gln) with a CADD score of 22.7 may contribute to CP as it will potentially affect 
splicing. 
This study provides further evidence that mutations in GRHL3 contribute to the risk of 
nonsyndromic CP in African populations, specifically, in the South African population. This is 
consistent with findings in other studies from Africa 12. More genetics and genomics studies need 

































































































PD D -5.50 26.7 n/a Cleft palate 
chr1:24331440 
 





















Benign T n/a 22.7 PAS Right Cleft lip  
and Alveolus 
 “c” refers to the coding sequence position within the GRHL3 transcript, NM_198173.3 “p” refers to amino acid substitutions. Amino acid 
substitution is for the GRHL3 isoform 2 transcript, NP_937816. 
1Kg, 1000 Genomes; B, benign; CS, Combined Annotation Dependent Depletion 8 score; D, deleterious; EVS, Exome Variant Server; gAD, 
Genome Aggregation Database; HGVS, Human Genome Variation Society; HSF, Human Splicing Finder; P, Polyphen; PAS, potential alteration of 




























Figure 2: Chromatograph of p.Asp169Gly variant in index patient, father and control 
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